onclive· 2mo ago
save<![CDATA[Perioperative Durvalumab Plus Neoadjuvant EV Displays EFS, OS Benefits vs SOC in MIBC]]>
May 14, 2026read original ↗
<![CDATA[Perioperative durvalumab plus EV showed positive topline efficacy findings in MIBC.]]>
The original article is no longer reachable from this URL.
read full article on onclive ↗🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that